Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer-Reference-Cited by-同舟云学术

Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer

Published:2018-12 Issue:1 Volume:16 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Okugawa Yoshinaga,Toiyama Yuji,Shigeyasu Kunitoshi,Yamamoto Akira,Shigemori Tsunehiko,Yin Chengzeng,Ichikawa Takashi,Yasuda Hiromi,Fujikawa Hiroyuki,Yoshiyama Shigeyuki,Hiro Junichiro,Ohi Masaki,Araki Toshimitsu,Kusunoki Masato,Goel Ajay^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-018-1740-z.pdf

Reference34 articles.

1. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010;79:321–49.

2. Savva YA, Rieder LE, Reenan RA. The ADAR protein family. Genome Biol. 2012;13:252.

3. Slotkin W, Nishikura K. Adenosine-to-inosine RNA editing and human disease. Genome Med. 2013;5:105.

4. Farajollahi S, Maas S. Molecular diversity through RNA editing: a balancing act. Trends Genet TIG. 2010;26:221–30.

5. Qi L, Chan TH, Tenen DG, Chen L. RNA editome imbalance in hepatocellular carcinoma. Can Res. 2014;74:1301–6.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer;Molecular Carcinogenesis;2024-09-06

2. RNA epigenetic modifications in digestive tract cancers: Friends or foes;Pharmacological Research;2024-08

3. ADAR1: from basic mechanisms to inhibitors;Trends in Cell Biology;2024-07

4. ARID1A loss promotes RNA editing of CDK13 in an ADAR1-dependent manner;BMC Biology;2024-06-05

5. The implication of integrative multiple RNA modification-based subtypes in gastric cancer immunotherapy and prognosis;iScience;2024-02